PALB2: The hub of a network of tumor suppressors involved in DNA damage responses
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
PALB2 was first identified as a partner of BRCA2 that mediates its recruitment to sites of DNA damage. PALB2 was subsequently found as a tumor suppressor gene. Inherited heterozygosity for this gene is associated with an increased risk of cancer of the breast and other sites. Additionally, biallelic mutation of PALB2 is linked to Fanconi anemia, which also has an increased risk of developing malignant disease. Recent work has identified numerous interactions of PALB2, suggesting that it functions in a network of proteins encoded by tumor suppressors. Notably, many of these tumor suppressors are related to the cellular response to DNA damage. The recruitment of PALB2 to DNA double-strand breaks at the head of this network is via a ubiquitin-dependent signaling pathway that involves the RAP80, Abraxas and BRCA1 tumor suppressors. Next, PALB2 interacts with BRCA2, which is a tumor suppressor, and with the RAD51 recombinase. These interactions promote DNA repair by homologous recombination (HR). More recently, PALB2 has been found to bind the RAD51 paralog, RAD51C, as well as the translesion polymerase pol η, both of which are tumor suppressors with functions in HR. Further, an interaction with MRG15, which is related to chromatin regulation, may facilitate DNA repair in damaged chromatin. Finally, PALB2 interacts with KEAP1, a regulator of the response to oxidative stress. The PALB2 network appears to mediate the maintenance of genome stability, may explain the association of many of the corresponding genes with similar spectra of tumors, and could present novel therapeutic opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802 · cited 1×
“confer 57% and 49% lifetime risks of developing breast cancer by one estimate [10].”
BackgroundZhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · cited 13×
“Hast BE, Goldfarb D, Mulvaney KM, Hast MA, Siesser PF, Yan F, Hayes DN, Major MB. Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination.”
BackgroundInfluentialInteraction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Biallelic Inactivation of BRCA2 in Fanconi Anemia
Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149 · cited 6×
“Cells from FA patients with biallelic mutation of BRCA2 have similar defects in the DNA damage response [26, 81].”
BackgroundInfluentialSchlacher, K., Wu, H., & Jasin, M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.015 · Cited by 936
MDC1 is a mediator of the mammalian DNA damage checkpoint
Stewart, G. S., Wang, B., Bignell, C. R., Taylor, A. M. R., & Elledge, S. J. (2003) · Nature · doi:10.1038/nature01446 · Cited by 874 · cited 2×
“Further, RNF8 binds to the MDC1 checkpoint mediator [83–85], and MDC1 is also required upstream of RNF8 in the recruitment of BRCA1 [86] and PALB2 [62] to sites of DNA damage.”
BackgroundControl of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2
Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826
The Breast Cancer Susceptibility Collaboration (UK), Seal, S., Thompson, D., Renwick, A., Elliott, A., Kelly, P., Barfoot, R., Chagtai, T., Jayatilake, H., Ahmed, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1902 · Cited by 746
Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response
Wang, B., Matsuoka, S., Ballif, B. A., Zhang, D., Smogorzewska, A., Gygi, S. P., & Elledge, S. J. (2007) · Science · doi:10.1126/science.1139476 · Cited by 695
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins
Wang, W. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2159 · Cited by 663 · cited 1×
“The identification of tumor suppressor genes has been highly important for understanding how tumors develop (reviewed in [1, 2]).”
BackgroundBiallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Reid, S., Schindler, D., Hanenberg, H., Barker, K., Hanks, S., Kalb, R., Neveling, K., Kelly, P., Seal, S., Freund, M., et al. (2007) · Nature Genetics · doi:10.1038/ng1947 · Cited by 642
The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance
Bouwman, P., & Jonkers, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3342 · Cited by 615 · cited 1×
“Further, the repair of DSBs modulates the therapeutic response to radiation and to a variety of chemotherapeutic agents [22, 23], many of which induce DSBs as a result of replication fork collapse or as an intermediate of repair.”
BackgroundMurr, R., Loizou, J. I., Yang, Y.-G., Cuenin, C., Li, H., Wang, Z.-Q., & Herceg, Z. (2006) · Nature Cell Biology · doi:10.1038/ncb1343 · Cited by 613
Yang, D., Khan, S., Sun, Y., Hess, K., Shmulevich, I., Sood, A. K., & Zhang, W. (2011) · JAMA · doi:10.1001/jama.2011.1456 · Cited by 599
Ubiquitin-Binding Protein RAP80 Mediates BRCA1-Dependent DNA Damage Response
Kim, H., Chen, J., & Yu, X. (2007) · Science · doi:10.1126/science.1139621 · Cited by 540
Ten Genes for Inherited Breast Cancer
Walsh, T., & King, M.-C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.010 · Cited by 477
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2
Xia, B., Dorsman, J. C., Ameziane, N., de Vries, Y., Rooimans, M. A., Sheng, Q., Pals, G., Errami, A., Gluckman, E., Llera, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1942 · Cited by 465 · cited 5×
“Defects of such mutants for DNA repair by HR were initially attributed to perturbation of BRCA2 function [24, 53, 60].”
BackgroundInfluentialThe DNA helicase BRIP1 is defective in Fanconi anemia complementation group J
Levitus, M., Waisfisz, Q., Godthelp, B. C., Vries, Y. D., Hussain, S., Wiegant, W. W., Elghalbzouri-Maghrani, E., Steltenpool, J., Rooimans, M. A., Pals, G., et al. (2005) · Nature Genetics · doi:10.1038/ng1625 · Cited by 432
Mutation of the RAD51C gene in a Fanconi anemia–like disorder
Vaz, F., Hanenberg, H., Schuster, B., Barker, K., Wiek, C., Erven, V., Neveling, K., Endt, D., Kesterton, I., Autore, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.570 · Cited by 408 · cited 5×
“The surviving patient did not have cancer or display hematological abnormalities through age ten, which is not unusual in FA [30].”
BackgroundInfluentialLitman, R., Peng, M., Jin, Z., Zhang, F., Zhang, J., Powell, S., Andreassen, P. R., & Cantor, S. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.004 · Cited by 396
Self-citationThe BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia
Levran, O., Attwooll, C., Henry, R. T., Milton, K. L., Neveling, K., Rio, P., Batish, S. D., Kalb, R., Velleuer, E., Barral, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1624 · Cited by 370
Chk2 Phosphorylation of BRCA1 Regulates DNA Double-Strand Break Repair
Zhang, J., Willers, H., Feng, Z., Ghosh, J. C., Kim, S., Weaver, D. T., Chung, J. H., Powell, S. N., & Xia, F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.708-718.2004 · Cited by 323
CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response
Kim, H., Huang, J., & Chen, J. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1277 · Cited by 212
Chun, J., Buechelmaier, E. S., & Powell, S. N. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00465-12 · Cited by 207
BACH1 is a DNA repair protein supporting BRCA1 damage response
Peng, M., Litman, R., Jin, Z., Fong, G., & Cantor, S. B. (2006) · Oncogene · doi:10.1038/sj.onc.1209257 · Cited by 88
Nikkilä, J., Coleman, K. A., Morrissey, D., Pylkäs, K., Erkko, H., Messick, T. E., Karppinen, S.-M., Amelina, A., Winqvist, R., & Greenberg, R. A. (2009) · Oncogene · doi:10.1038/onc.2009.33 · Cited by 63
Solyom, S., Aressy, B., Pylkäs, K., Patterson-Fortin, J., Hartikainen, J. M., Kallioniemi, A., Kauppila, S., Nikkilä, J., Kosma, V.-M., Mannermaa, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003223 · Cited by 59 · cited 1×
“Among these, RAP80 and Abraxas are also tumor suppressors [4, 160].”
Background
Research works printed but not linked: 131
- Moynahan, 2010, Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis, Nat. Rev. Mol. Cell Biol., 11, 196, 10.1038/nrm2851 · DOI · Paper page
- Park, 2012, Rare mutations in XRCC2 increase the risk of breast cancer, Am. J. Hum. Genet., 90, 734, 10.1016/j.ajhg.2012.02.027 · DOI · Paper page
- Meindl, 2010, Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene, Nat. Genet., 42, 410, 10.1038/ng.569 · DOI · Paper page
- Vuorela, 2011, Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility, Breast Cancer Res. Treat., 130, 1003, 10.1007/s10549-011-1677-x · DOI
- Miki, 1994, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, 266, 66, 10.1126/science.7545954 · DOI · Paper page
- Wooster, 1995, Identification of the breast cancer susceptibility gene BRCA2, Nature, 378, 789, 10.1038/378789a0 · DOI · Paper page
- Pal, 2005, BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases, Cancer, 104, 2807, 10.1002/cncr.21536 · DOI · Paper page
- Moran, 2012, Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations, Fam. Cancer, 11, 235, 10.1007/s10689-011-9506-2 · DOI · Paper page
- Lal, 2000, Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations, Cancer Res., 60, 409
- Scully, 2013, Double strand break repair functions of histone H2AX, Mutat. Res., 750, 5, 10.1016/j.mrfmmm.2013.07.007 · DOI · Paper page
- Mimitou, 2009, DNA end resection: many nucleases make light work, DNA Repair, 8, 983, 10.1016/j.dnarep.2009.04.017 · DOI · Paper page
- Suwaki, 2011, RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis, Semin. Cell Dev. Biol., 22, 898, 10.1016/j.semcdb.2011.07.019 · DOI · Paper page
- Chen, 2008, Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair, J. Biol. Chem., 283, 7713, 10.1074/jbc.M710245200 · DOI · Paper page
- Coleman, 2011, The BRCA1-RAP80 complex regulates DNA repair mechanism utilization by restricting end resection, J. Biol. Chem., 286, 13669, 10.1074/jbc.M110.213728 · DOI · Paper page
- Kitagawa, 2004, Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway, Genes Dev., 18, 1423, 10.1101/gad.1200304 · DOI · Paper page
- Moynahan, 2001, Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation, Cancer Res., 61, 4842
- Barker, 2010, Enhancing radiotherapy through a greater understanding of homologous recombination, Semin. Radiat. Oncol., 20, 267, 10.1016/j.semradonc.2010.05.001 · DOI
- Stoepker, 2011, SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype, Nat. Genet., 43, 138, 10.1038/ng.751 · DOI · Paper page
- Kim, 2011, Mutations of the SLX4 gene in Fanconi anemia, Nat. Genet., 43, 142, 10.1038/ng.750 · DOI · Paper page
- Bogliolo, 2013, Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia, Am. J. Hum. Genet., 92, 800, 10.1016/j.ajhg.2013.04.002 · DOI · Paper page
- de Winter, 2000, Isolation of a cDNA representing the Fanconi anemia complementation group E gene, Am. J. Hum. Genet., 67, 1306, 10.1016/S0002-9297(07)62959-0 · DOI · Paper page
- de Winter, 2000, The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM, Nat. Genet., 24, 15, 10.1038/71626 · DOI · Paper page
- de Winter, 1998, The Fanconi anaemia group G gene FANCG is identical with XRCC9, Nat. Genet., 20, 281, 10.1038/3093 · DOI · Paper page
- Dorsman, 2007, Identification of the Fanconi anemia complementation group I gene, FANCI, Cell. Oncol., 29, 211
- c. Fanconi anaemia/Breast cancer, 1996, Positional cloning of the Fanconi anaemia group A gene, Nat. Genet., 14, 324, 10.1038/ng1196-324 · DOI · Paper page
- Lo Ten Foe, 1996, Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA, Nat. Genet., 14, 320, 10.1038/ng1196-320 · DOI · Paper page
- Sims, 2007, FANCI is a second monoubiquitinated member of the Fanconi anemia pathway, Nat. Struct. Mol. Biol., 14, 564, 10.1038/nsmb1252 · DOI · Paper page
- Smogorzewska, 2007, Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair, Cell, 129, 289, 10.1016/j.cell.2007.03.009 · DOI · Paper page
- Strathdee, 1992, Cloning of cDNAs for Fanconi's anaemia by functional complementation, Nature, 356, 763, 10.1038/356763a0 · DOI · Paper page
- Timmers, 2001, Positional cloning of a novel Fanconi anemia gene, FANCD2, Mol. Cell, 7, 241, 10.1016/S1097-2765(01)00172-1 · DOI · Paper page
- Meetei, 2003, A novel ubiquitin ligase is deficient in Fanconi anemia, Nat. Genet., 35, 165, 10.1038/ng1241 · DOI · Paper page
- Meetei, 2004, X-linked inheritance of Fanconi anemia complementation group B, Nat. Genet., 36, 1219, 10.1038/ng1458 · DOI · Paper page
- Meetei, 2005, A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M, Nat. Genet., 37, 958, 10.1038/ng1626 · DOI · Paper page
- Kee, 2012, Molecular pathogenesis and clinical management of Fanconi anemia, J. Clin. Invest., 122, 3799, 10.1172/JCI58321 · DOI · Paper page
- Kottemann, 2013, Fanconi anaemia and the repair of Watson and Crick DNA crosslinks, Nature, 493, 356, 10.1038/nature11863 · DOI · Paper page
- Andreassen, 2009, Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy, Curr. Cancer Drug Targets, 9, 101, 10.2174/156800909787314011 · DOI
- Nakanishi, 2011, Homology-directed Fanconi anemia pathway cross-link repair is dependent on DNA replication, Nat. Struct. Mol. Biol., 18, 500, 10.1038/nsmb.2029 · DOI · Paper page
- Rahman, 2007, PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene, Nat. Genet., 39, 165, 10.1038/ng1959 · DOI · Paper page
- Erkko, 2007, A recurrent mutation in PALB2 in Finnish cancer families, Nature, 446, 316, 10.1038/nature05609 · DOI · Paper page
- Takata, 2001, Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs, Mol. Cell. Biol., 21, 2858, 10.1128/MCB.21.8.2858-2866.2001 · DOI · Paper page
- Abbott, 1998, Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells, J. Natl. Cancer Inst., 90, 978, 10.1093/jnci/90.13.978 · DOI · Paper page
- Ghosh, 2014, Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes, Am. J. Pathol., 184, 260, 10.1016/j.ajpath.2013.09.023 · DOI
- Park, 2013, Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair, Oncogene
- Tischkowitz, 2007, Analysis of PALB2/FANCN-associated breast cancer families, Proc. Natl. Acad. Sci. U. S. A., 104, 6788, 10.1073/pnas.0701724104 · DOI · Paper page
- Zhang, 2012, MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination, J. Cell Sci., 125, 6049, 10.1242/jcs.111872 · DOI
- Zhang, 2009, PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2, Mol. Cancer Res., 7, 1110, 10.1158/1541-7786.MCR-09-0123 · DOI · Paper page
- Zhang, 2009, PALB2 links BRCA1 and BRCA2 in the DNA-damage response, Curr. Biol., 19, 524, 10.1016/j.cub.2009.02.018 · DOI · Paper page
- Hayakawa, 2010, MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks, J. Cell Sci., 123, 1124, 10.1242/jcs.060178 · DOI · Paper page
- Sy, 2009, PALB2 is an integral component of the BRCA complex required for homologous recombination repair, Proc. Natl. Acad. Sci. U. S. A., 106, 7155, 10.1073/pnas.0811159106 · DOI · Paper page
- Sy, 2009, PALB2 regulates recombinational repair through chromatin association and oligomerization, J. Biol. Chem., 284, 18302, 10.1074/jbc.M109.016717 · DOI
- Oliver, 2009, Structural basis for recruitment of BRCA2 by PALB2, EMBO Rep., 10, 990, 10.1038/embor.2009.126 · DOI · Paper page
- Tischkowitz, 2010, PALB2/FANCN: recombining cancer and Fanconi anemia, Cancer Res., 70, 7353, 10.1158/0008-5472.CAN-10-1012 · DOI · Paper page
- Sy, 2009, MRG15 is a novel PALB2-interacting factor involved in homologous recombination, J. Biol. Chem., 284, 21127, 10.1074/jbc.C109.023937 · DOI · Paper page
- Martrat, 2011, Exploring the link between MORF4L1 and risk of breast cancer, Breast Cancer Res., 13, R40, 10.1186/bcr2862 · DOI
- Ma, 2012, PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function, Mol. Cell. Biol., 32, 1506, 10.1128/MCB.06271-11 · DOI · Paper page
- Hast, 2013, Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination, Cancer Res., 73, 2199, 10.1158/0008-5472.CAN-12-4400 · DOI · Paper page
- Hayes, 2009, NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer, Trends Biochem. Sci., 34, 176, 10.1016/j.tibs.2008.12.008 · DOI · Paper page
- Fruehauf, 2007, Reactive oxygen species: a breath of life or death?, Clin. Cancer Res., 13, 789, 10.1158/1078-0432.CCR-06-2082 · DOI · Paper page
- Sosa, 2013, Oxidative stress and cancer: an overview, Ageing Res. Rev., 12, 376, 10.1016/j.arr.2012.10.004 · DOI · Paper page
- Lupas, 1996, Coiled coils: new structures and new functions, Trends Biochem. Sci., 21, 375, 10.1016/S0968-0004(96)10052-9 · DOI · Paper page
- Scully, 1997, Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage, Cell, 90, 425, 10.1016/S0092-8674(00)80503-6 · DOI · Paper page
- Yuan, 1999, BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo, Cancer Res., 59, 3547
- Moynahan, 2001, BRCA2 is required for homology-directed repair of chromosomal breaks, Mol. Cell, 7, 263, 10.1016/S1097-2765(01)00174-5 · DOI · Paper page
- Mermershtain, 2013, Structural mechanisms underlying signaling in the cellular response to DNA double strand breaks, Mutat. Res., 750, 15, 10.1016/j.mrfmmm.2013.07.004 · DOI
- Huen, 2007, RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly, Cell, 131, 901, 10.1016/j.cell.2007.09.041 · DOI · Paper page
- Kolas, 2007, Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase, Science, 318, 1637, 10.1126/science.1150034 · DOI · Paper page
- Mailand, 2007, RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins, Cell, 131, 887, 10.1016/j.cell.2007.09.040 · DOI · Paper page
- Sobhian, 2007, RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites, Science, 316, 1198, 10.1126/science.1139516 · DOI · Paper page
- Buisson, 2012, PALB2 self-interaction controls homologous recombination, Nucleic Acids Res., 40, 10312, 10.1093/nar/gks807 · DOI
- Dray, 2010, Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2, Nat. Struct. Mol. Biol., 17, 1255, 10.1038/nsmb.1916 · DOI · Paper page
- Buisson, 2010, Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination, Nat. Struct. Mol. Biol., 17, 1247, 10.1038/nsmb.1915 · DOI · Paper page
- Itoh, 1999, Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, Genes Dev., 13, 76, 10.1101/gad.13.1.76 · DOI · Paper page
- Klaunig, 2010, Oxidative stress and oxidative damage in carcinogenesis, Toxicol. Pathol., 38, 96, 10.1177/0192623309356453 · DOI · Paper page
- Yang, 2002, BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure, Science, 297, 1837, 10.1126/science.297.5588.1837 · DOI · Paper page
- Siaud, 2011, Plasticity of BRCA2 function in homologous recombination: genetic interactions of the PALB2 and DNA binding domains, PLoS Genet., 7, e1002409, 10.1371/journal.pgen.1002409 · DOI · Paper page
- Esashi, 2007, Stabilization of RAD51 nucleoprotein filaments by the C-terminal region of BRCA2, Nat. Struct. Mol. Biol., 14, 468, 10.1038/nsmb1245 · DOI · Paper page
- Martin, 2007, RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors, Cancer Res., 67, 9658, 10.1158/0008-5472.CAN-07-0290 · DOI · Paper page
- Yata, 2012, Plk1 and CK2 act in concert to regulate Rad51 during DNA double strand break repair, Mol. Cell, 45, 371, 10.1016/j.molcel.2011.12.028 · DOI · Paper page
- Antoniou, 2007, RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies, Am. J. Hum. Genet., 81, 1186, 10.1086/522611 · DOI · Paper page
- Bleuyard, 2012, ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair, EMBO Rep., 13, 135, 10.1038/embor.2011.243 · DOI
- Xie, 2012, Structural basis for molecular interactions involving MRG domains: implications in chromatin biology, Structure, 20, 151, 10.1016/j.str.2011.10.019 · DOI
- Smeenk, 2013, The chromatin response to DNA breaks: leaving a mark on genome integrity, Annu. Rev. Biochem., 82, 55, 10.1146/annurev-biochem-061809-174504 · DOI · Paper page
- Gospodinov, 2013, Shaping chromatin for repair, Mutat. Res., 752, 45, 10.1016/j.mrrev.2012.10.001 · DOI
- Chen, 2010, Emerging role of the MORF/MRG gene family in various biological processes, including aging, Ann. N. Y. Acad. Sci., 1197, 134, 10.1111/j.1749-6632.2010.05197.x · DOI
- Sapountzi, 2006, Cellular functions of TIP60, Int. J. Biochem. Cell Biol., 38, 1496, 10.1016/j.biocel.2006.03.003 · DOI · Paper page
- Ikura, 2007, DNA damage-dependent acetylation and ubiquitination of H2AX enhances chromatin dynamics, Mol. Cell. Biol., 27, 7028, 10.1128/MCB.00579-07 · DOI · Paper page
- Yochum, 2002, Role for the mortality factors MORF4, MRGX, and MRG15 in transcriptional repression via associations with Pf1, mSin3A, and Transducin-Like Enhancer of Split, Mol. Cell. Biol., 22, 7868, 10.1128/MCB.22.22.7868-7876.2002 · DOI
- Hayakawa, 2007, RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation, Genes Cells, 12, 811, 10.1111/j.1365-2443.2007.01089.x · DOI
- Zhang, 2006, Structure of human MRG15 chromo domain and its binding to Lys36-methylated histone H3, Nucleic Acids Res., 34, 6621, 10.1093/nar/gkl989 · DOI · Paper page
- Rio Frio, 2010, Mutation analysis of the gene encoding the PALB2-binding protein MRG15 in BRCA1/2-negative breast cancer families, J. Hum. Genet., 55, 842, 10.1038/jhg.2010.112 · DOI
- Stirnimann, 2010, WD40 proteins propel cellular networks, Trends Biochem. Sci., 35, 565, 10.1016/j.tibs.2010.04.003 · DOI · Paper page
- Buisson, 2014, Breast cancer proteins PALB2 and BRCA2 stimulate polymerase eta in recombination-associated DNA synthesis at blocked replication forks, Cell Rep., 6, 553, 10.1016/j.celrep.2014.01.009 · DOI · Paper page
- Menzel, 2011, A genetic screen identifies BRCA2 and PALB2 as key regulators of G2 checkpoint maintenance, EMBO Rep., 12, 705, 10.1038/embor.2011.99 · DOI · Paper page
- Phelan, 1996, Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families, Nat. Genet., 13, 120, 10.1038/ng0596-120 · DOI · Paper page
- Teng, 1996, Low incidence of BRCA2 mutations in breast carcinoma and other cancers, Nat. Genet., 13, 241, 10.1038/ng0696-241 · DOI · Paper page
- Potapova, 2008, Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer, Cancer Res., 68, 998, 10.1158/0008-5472.CAN-07-2418 · DOI
- Walsh, 2011, Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing, Proc. Natl. Acad. Sci. U. S. A., 108, 18032, 10.1073/pnas.1115052108 · DOI · Paper page
- Hirsch, 2004, Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood, Blood, 103, 2554, 10.1182/blood-2003-06-1970 · DOI · Paper page
- Wagner, 2004, Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia, Blood, 103, 3226, 10.1182/blood-2003-09-3138 · DOI · Paper page
- Makde, 2010, Structure of RCC1 chromatin factor bound to the nucleosome core particle, Nature, 467, 562, 10.1038/nature09321 · DOI · Paper page
- Miller, 2004, Domain mapping of the Rad51 paralog protein complexes, Nucleic Acids Res., 32, 169, 10.1093/nar/gkg925 · DOI
- Badie, 2009, RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation, J. Cell Biol., 185, 587, 10.1083/jcb.200811079 · DOI · Paper page
- Liu, 2004, RAD51C is required for Holliday junction processing in mammalian cells, Science, 303, 243, 10.1126/science.1093037 · DOI · Paper page
- Liu, 2002, Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells, Nucleic Acids Res., 30, 1009, 10.1093/nar/30.4.1009 · DOI · Paper page
- Masson, 2001, Identification and purification of two distinct complexes containing the five RAD51 paralogs, Genes Dev., 15, 3296, 10.1101/gad.947001 · DOI · Paper page
- Wiese, 2002, Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells, Nucleic Acids Res., 30, 1001, 10.1093/nar/30.4.1001 · DOI · Paper page
- Schild, 2000, Evidence for simultaneous protein interactions between human Rad51 paralogs, J. Biol. Chem., 275, 16443, 10.1074/jbc.M001473200 · DOI · Paper page
- Somyajit, 2012, Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility, J. Biol. Chem., 287, 3366, 10.1074/jbc.M111.311241 · DOI · Paper page
- Hellebrand, 2011, Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer, Hum. Mutat., 32, E2176, 10.1002/humu.21478 · DOI
- Liu, 2007, Role of RAD51C and XRCC3 in genetic recombination and DNA repair, J. Biol. Chem., 282, 1973, 10.1074/jbc.M609066200 · DOI · Paper page
- Kawamoto, 2005, Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis, Mol. Cell, 20, 793, 10.1016/j.molcel.2005.10.016 · DOI · Paper page
- Masutani, 1999, The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta, Nature, 399, 700, 10.1038/21447 · DOI · Paper page
- Masutani, 1999, Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity, EMBO J., 18, 3491, 10.1093/emboj/18.12.3491 · DOI · Paper page
- Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
- Bowman-Colin, 2013, Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer, Proc. Natl. Acad. Sci. U. S. A., 110, 8632, 10.1073/pnas.1305362110 · DOI
- Nikkila, 2013, Heterozygous mutations in PALB2 cause DNA replication and damage response defects, Nat. Commun., 4, 2578, 10.1038/ncomms3578 · DOI · Paper page
- Schlacher, 2011, Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11, Cell, 145, 529, 10.1016/j.cell.2011.03.041 · DOI · Paper page
- Arlt, 2004, BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function, Mol. Cell. Biol., 24, 6701, 10.1128/MCB.24.15.6701-6709.2004 · DOI · Paper page
- De Haro, 2010, Metnase promotes restart and repair of stalled and collapsed replication forks, Nucleic Acids Res., 38, 5681, 10.1093/nar/gkq339 · DOI
- Bryant, 2005, Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase, Nature, 434, 913, 10.1038/nature03443 · DOI · Paper page
- Farmer, 2005, Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy, Nature, 434, 917, 10.1038/nature03445 · DOI · Paper page
- Min, 2013, RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib, Mol. Cancer Ther., 12, 865, 10.1158/1535-7163.MCT-12-0950 · DOI · Paper page
- Hojfeldt, 2013, Histone lysine demethylases as targets for anticancer therapy, Nat. Rev. Drug Discov., 12, 917, 10.1038/nrd4154 · DOI · Paper page
- Zagni, 2013, Histone methyltransferase inhibitors: novel epigenetic agents for cancer treatment, Curr. Med. Chem., 20, 167, 10.2174/092986713804806667 · DOI
- Bhattacharyya, 2000, The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin, J. Biol. Chem., 275, 23899, 10.1074/jbc.C000276200 · DOI · Paper page
- Swisher, 2012, Molecular scores to predict ovarian cancer outcomes: a worthy goal, but not ready for prime time, J. Natl. Cancer Inst., 104, 642, 10.1093/jnci/djs203 · DOI
- Konstantinopoulos, 2010, Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer, J. Clin. Oncol., 28, 3555, 10.1200/JCO.2009.27.5719 · DOI · Paper page
- Pennington, 2014, Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas, Clin. Cancer Res., 20, 764, 10.1158/1078-0432.CCR-13-2287 · DOI · Paper page
- Alsop, 2012, BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group, J. Clin. Oncol., 30, 2654, 10.1200/JCO.2011.39.8545 · DOI · Paper page
- Willers, 2009, Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies, Mol. Cancer Res., 7, 1304, 10.1158/1541-7786.MCR-09-0149 · DOI · Paper page
- Yin, 2012, RAP80 is critical in maintaining genomic stability and suppressing tumor development, Cancer Res., 72, 5080, 10.1158/0008-5472.CAN-12-1484 · DOI · Paper page
Cited by
The control of DNA repair by the cell cycle
Hustedt, N., & Durocher, D. (2017) · Nature Cell Biology · doi:10.1038/ncb3452 · Cited by 738
Inherited Mutations in Women With Ovarian Carcinoma
Norquist, B. M., Harrell, M. I., Brady, M. F., Walsh, T., Lee, M. K., Gulsuner, S., Bernards, S. S., Casadei, S., Yi, Q., Burger, R. A., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5495 · Cited by 769
RETRACTED ARTICLE: A mechanism for the suppression of homologous recombination in G1 cells
Orthwein, A., Noordermeer, S. M., Wilson, M. D., Landry, S., Enchev, R. I., Sherker, A., Munro, M., Pinder, J., Salsman, J., Dellaire, G., et al. (2015) · Nature · doi:10.1038/nature16142 · Cited by 471
RetractedWhole-genome sequencing of triple-negative breast cancers in a population-based clinical study
Staaf, J., Glodzik, D., Bosch, A., Vallon-Christersson, J., Reuterswärd, C., Häkkinen, J., Degasperi, A., Amarante, T. D., Saal, L. H., Hegardt, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0582-4 · Cited by 307
“PALB2, RAD51C and BRCA2 are involved in a complex that stimulates strand invasion of the RAD51 nucleoprotein filament 18,19 , a critical step in HR-related repair.”
Metadata
- Authors
- Park, J.-Y., Zhang, F., & Andreassen, P. R.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 1846
- Issue
- 1
- Pages
- 263-275
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2042787708
- Cited by
- 78
- References
- 29
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- NIH (R01 HL085587)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.